Olaparib With Ceralasertib in Recurrent Osteosarcoma
Olaparib With Ceralasertib in Recurrent Osteosarcoma
Active, not recruiting · NCT04417062 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olaparib With Ceralasertib in Recurrent Osteosarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Active, not recruiting | Phase 2 | 2026-09-24 | NCT04417062 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Dana-Farber Cancer Institute | 324 |
| Osteosarcoma Institute | 2 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institite | Boston | United States | 4 |
| MD Anderson | Houston | United States | 56 |
| Memorial Sloan Kettering | New York | United States | 27 |
| UCSF Benioff Children's Hospital; UCSF Pediatrics Hematology Oncology | San Francisco | United States | 1 |